Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care

• Status: Terminated
• Trial end date: 2002-07-01
• Target enrollment: 0
• Participant gender: All

Summary

To determine the efficacy and to measure the complications of prophylactic anticoagulation using low-molecular weight heparin in adult cancer patients under palliative care

Details

• Lead Sponsor: University Hospital, Geneva
• Treatments: Nadroparin

Criteria

Inclusion Criteria:

• Cancer patients in palliative care

• Patients fully informed about their condition

• Signed informed consent

• No exclusion criteria

Exclusion Criteria:

• Absence of advanced cancer

• Cancer previously cured

• Venous thromboembolism diagnosed within 6 months prior to inclusion

• Absence of discerning capacity

• Active anti-thrombotic treatment with heparins or coumarines

• Thrombocytopenia <50G/l

• PTT >45sec

• TP<35%

• Active bleeding

• Renal failure <20ml/min

• Past history of heparin-induced thrombocytopenia